Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Monday, July 27, 2015

HealthWise: Hepatitis C and Pain—Part 2, by Lucinda K. Porter, RN

Originally published July 1, 2015

Last month, I talked about hepatitis C and pain, and presented information about over-the-counter and prescription pain medication. Nonsteroidal anti-inflammatory drugs (NSAIDS) and opioids are effective painkillers, but they are associated with the risk of medical complications. This month I focus on pain management techniques that have little or no risk of injuring the liver or other organs in the body. I start with the controversial one—marijuana.  

Cannabis
Marijuana (Cannabis sativa) is slowly emerging from its status as the cause of “reefer madness” to a more reputable one showing potential medical benefits. However, before running out and buying some weed and a bag of Cheese Doodles, let’s explore these questions:
  • Is marijuana effective for reducing pain?
  • What is marijuana’s affect on the liver and hepatitis C?
First, let’s get one big frustrating fact out of the way: Marijuana is classified as a Schedule 1 drug. Drugs with a schedule 1 designation are deemed as having a high potential for abuse and no accepted medical use. Marijuana is tucked in there along with heroin, LSD, peyote, and ecstasy. Politicians determined this, not scientists. Because of this classification, marijuana is nearly impossible to obtain and test in clinical research. The bureaucracy is enormous, and permission is hard to get. In 2010, Time magazine summed it up this way, “Pot is listed as Schedule 1 because science hasn’t found an accepted medical use for it, but science can’t find a medical use for it because it is listed as Schedule 1.”

It is hard to imagine that marijuana is classified as a Schedule 1 drug when there has never been a reported death from marijuana overdose. Compare this to annual deaths from acetaminophen (300) or nonsteroidal anti-inflammatory drugs (7,000-10,000), and opioids (16,000). Compare marijuana’s zero deaths to those from legally obtainable substances, such as alcohol (88,000) or tobacco (480,000 including second-hand), and cannabis seems much safer.

This is not to say that marijuana isn’t without risk. In Colorado, two cannabis-related deaths are under investigation; one a suicide, the other a homicide in which other substances were involved. Also disturbing is the fact that the number of auto accidents have risen in Colorado since the legalization of pot.

These few deaths are hardly worth condemning pot for, especially since marijuana use may be causing a drop in the number of deaths from prescription opioids. States with liberal marijuana laws had a 25 percent reduction in opioid deaths. Cannabis is also associated with lower death rates in patients with traumatic injuries. That is just the beginning. The potential benefits are so many, that U.S. Surgeon General, Vivek Murthy said, “We have some preliminary data showing that for certain medical conditions and symptoms, marijuana can be helpful.”

Is marijuana effective for pain? Yes! I could write pages on this. The bottom line is that cannabinoids (a chemical compound found in a number of plants, including Cannabis sativa) interact with specific receptors in the brain. This appears to reduce pain and inflammation.

Will marijuana cause liver injury? It’s not well researched, but probably not. A Canadian study of 690 participants led by Laurence Brune and colleagues found, “Marijuana smoking does not accelerate progression of liver disease in HIV–Hepatitis C coinfection.” (Clinical Infectious Disease, Sep 2013). Previous studies have had mixed results.

What is marijuana’s effect on hepatitis C? The studies have been mixed. There is some research suggesting that marijuana may lower immune response. However, cannabis is being used in cancer studies with favorable results. In short, we don’t know.

What are the downsides of marijuana use? There are quite a few, such as risks of addiction, cognitive impairment, increased bleeding risks, etc. Frankly, we don’t know all the risks since marijuana has not been rigorously researched. I suspect that a day will come when marijuana will come with a paper insert that will list all the potential drug interactions, side effects, and warnings. Until then, keep this in mind:  We don’t know if cannabis interacts with hepatitis C medications. Marijuana may interfere with drugs that are metabolized via the liver’s cytochrome P450 enzyme system. This may affect the dose of your hepatitis C medications. If you use marijuana, work with a doctor who will prescribe it, and show you how to use it medically and responsibly.
 
Note: If you are on or are being considered for liver transplantation, marijuana use can be a disqualifier. The state of California recently introduced legislation to prohibit marijuana use as a factor for disqualification for organ transplantation. Other states may follow suit, especially in the light of Congress’s latest legislation banning federal interference on state medical marijuana laws.
Some insurance companies and state Medicaid programs are requiring drug testing prior to approval of hepatitis C treatment. If your medical provider has prescribed treatment and you use pot, find out if there will be drug testing. If so, educate yourself about the washout period, or how to pass the test; it varies depending on how often you use marijuana.

Drug-Free Pain Control
Ideally, relieving pain without drugs is the safest approach. The trick is to work with a specialist who is trained in the art of introducing drug-free pain measures while slowly reducing pain medication. All sorts of drug-free techniques are used, such as acupuncture, massage, hypnosis. Below are three drug-free techniques worth considering.
 
1. Exercise: I was surprised to learn that exercise topped the list of ways to reduce chronic pain, particularly arthritic and inflammatory pain. Exercise also helps fibromyalgia, migraine headaches and back pain. Aerobic exercise seems to be the best, and the intensity is determined by what you can tolerate. Walking is great exercise because it doesn’t require anything more than a good pair of shoes, sunscreen, and a safe place to walk. Gardening, dancing, bicycling, swimming, yoga, and tai chi are other fun ways to stay fit. If you are new to exercise, be sure to talk to your medical provider before starting. Start slow and only do what feels comfortable. 

2. Meditation: There are countless studies documenting meditation’s profound effect on reducing pain. Personally, I couldn’t imagine sitting still while relaxed, let alone in pain, so I had to experiment with this one myself. It works. It wasn’t as good as a spinal block or sedation, but it was free and without risk. There are many ways to meditate, but probably the most well-known in the U.S. is mindfulness-based stress reduction (MBSR) developed by Jon Kabat-Zinn. MBSR is taught in hospitals, clinics, and communities. 

3. Quitting Smoking:  In “Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection,” Alexis Ogdie and colleagues reported that hepatitis C patients who smoked, had higher levels of joint pain. (BMC Musculoskeletal Disorders 2015) (See review of this article by Alan Franciscus here.) Granted, the study did not show that tobacco cessation would reduce pain, but we all know that smoking presents huge health risks. If you do decide to quit, seek professional help. Perhaps MBSR and exercise will help.

Final Words
I have tried to simplify a very complicated subject. Pain management deserves more than I gave it here. In nursing, I learned that pain is the fifth vital sign. In short, pain should be taken seriously. However, the tragic reality is that pain is understudied and poorly misunderstood. Some physicians over-prescribe painkillers; some under-prescribe them. The bottom line is that if your pain is not well controlled, ask to see a pain specialist.

Lucinda K. Porter, RN, is a long-time contributor to the HCV Advocate and author of Free from Hepatitis C and Hepatitis C One Step at a Time. Her blog is www.LucindaPorterRN.com

Resources
http://hcvadvocate.org/news/newsLetter/2015/advocate0715.html#2

A Brief Overview of Liver Toxic Herbs —Alan Franciscus, Editor-in-Chief

Originally Published July 1, 2015

A recent article appeared in Gastroenterology that provided an overview of herbal products. This review will focus on the important issues regarding the lack of standardization, possible contamination, some deceptive claims and a list of the herbs that have the most potential to harm the liver.

In the February 2015 edition of the HCV Advocate Mid-Month Newsletter, I wrote “Herbal Supplement Crackdown.”  The article was about four major chains selling herbal supplements in New York State that contained substances not listed on the package label.  Even more disconcerting was that many of the listed herbs when tested, could not be verified as being the actual labeled herbs. 
Some of the important issues raised in the current study included:
 
Standardization:
There are many factors that affect the potency of herbs such as what season grown, location planted and how much sun the herbs receive, fertilizer (and how much) used and many additional factors. 
For instance, a list of 25 commercial ginseng products from a local health food store was analyzed for ingredients—the ginseng concentrations were different than listed on the label. The difference in the concentrations could be correlated to the standardizations issues listed above.

Contamination and Adulteration:
Herbal products were tested and found to have pesticides and toxins as well as unlabeled drugs in the herbal products.  These types of issues were also found in the herbs analyzed in the New York herbal crackdown. 

Deceptive Marketing:
There have been advertisements that promote the use of herbs stating that some herbal products can help to treat certain conditions and even cure viral infections.  Herbs may provide some relief from particular illnesses and provide supportive care.  However, there never has been a study that has shown that an herb can cure a viral disease such as hepatitis C.  Be careful about these types of claims.

Most Common Liver Toxic Herbs:
The herbs listed below are the most common herbs that have been found to cause liver toxicity, liver injury, possible liver failure and death.  I have listed the common name (bolded), scientific name and the most common ailments the herb is used to treat:
  • Black cohosh (Cimicifuga racemose):  menopausal symptoms
  • Chaparral (Larrea tridentate): weight loss, rheumatic pain, antibiotic
  • Comfrey (Symphyturn officinale): Wound healing
  • Germander (Teucrium chamaedrys):  Weight loss
  • Greater celandine (Chelidonium majus):  Liver and biliary tract disease
  • Green tea extract (Camellia sinensis): General health, weight loss
  • Herbalife product line (Multi-ingredient): Mental health and weight loss
  • Kava kava (Piper methysticum):  mental health and well-being
  • Hydroxycut (multi-ingredient):  Weight loss
  • Oxy-Elite Pro (multi-ingredient):  Performance-enhancement,  weight loss
  • Saw palmetto (Serenoa repens):  Prostate disease
The good news about herbs is that the New York attorney general and 13 other states are petitioning Congress to investigate the herbal supplement industry.  Additionally, the states are requesting the Food and Drug Administration to provide more oversight to the herbal supplements industry.  Until that time, it is up to the consumer to advocate for themselves, dig deep and to stick to the old warning to consumers—buyer beware.

Resources:
http://hcvadvocate.org/news/newsLetter/2015/advocate0715.html#1

Sunday, July 26, 2015

New Zealand: Cost keeps cure out of reach for those with Hepatitis C

Craig Hopkins, 52, nearly died from liver failure after contracting Hepatitis C virus (HCV) from an amateur tattoo. His new liver developed HCV but was finally cured after treatment with a new unsubsidised drug made available on compassionate grounds.

Now Hepatitis C free, the 52-year-old is calling for Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) to be made available in New Zealand.

"I reckon it's really sad the drugs are not available. If they were, it would free up the operating tables and they wouldn't need to do so many liver transplants."

Read more...

Street Art Fair Raises Awareness About ‘Silent Killer’ Hepatitis C

DENVER (CBS4) – Local artists spent Sunday creating a mural to raise awareness about Hepatitis C. It’s a disease that patients call a silent killer.

Patients and survivors came out to the event to support World Hepatitis Day, including Rhonda Robineau. Today she is happy and healthy, but it wasn’t always that way.

Read more ...

Ireland: Faithfull promotes Hepatitis C awareness week

Singer songwriter Marianne Faithfull is set to front Ireland’s
first campaign to promote awareness of hepatitis C.

The 68-year-old will front The National Hepatitis C Awareness Week. The campaign takes place from July 27 to 31, and Faithfull will be the guest speaker at the launch of the campaign tomorrow at 6pm in the Smock Alley Theatre in Dublin.

Hepatitis C is a viral infection that affects the liver, causing it to become inflamed and not work as effectively in the body. It can be contracted via blood-to-blood contact with an infected person’s blood.

Speaking to The Sunday Times, Faithfull said she was diagnosed with the virus 23 years ago.

Read more...

Saturday, July 25, 2015

Canada: Quebec to start reimbursing for 'revolutionary' Hepatitis C treatment

Quebec has decided to reimburse “revolutionary” drugs that can cure Hepatitis C, but only for the sickest patients at first.

According to the rules adopted by the Régie de l’assurance maladie du Québec, some Quebecers with the disease will have to wait three years before getting access to new treatments.

The measures concern two drugs called Harvoni and Holkira Pak that are supposed to cure the condition in 8-12 weeks.

Read more...

Tuskegee launches hepatitis C virus testing initiative

In honor of the third annual National African American Hepatitis C Action Day today, the City of Tuskegee is taking steps to eradicate the hepatitis C virus (HCV) infection in its community, beginning with testing.

Mayor Johnny Ford of Tuskegee joined with national and local health leaders to discuss starting an initiative to diagnose and treat those infected with HCV in his area Friday morning.


C. Virginia Fields, president and CEO of the National Black Leadership Commission on AIDS, joined Ford in announcing that something must be done to counteract the spread of hepatitis C in the African American community.

Read more...